# CRISPR Therapeutics

Type: Company (CRSP)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/crispr-therapeutics
Canonical HTML page: https://gethealthbrief.com/entity/crispr-therapeutics

## Recent coverage (1 stories)

### FDA Expands Gene Therapy to Kids 2+, Offering $2.2M Cure for Sickle Cell
2026-07-09 07:50:49 · Sentiment: Bullish · Impact: 8/10 · Sources: 20

The FDA’s approval of Casgevy for children as young as two promises to shift pediatric sickle cell care from lifelong management to a one-time curative intervention, but raises urgent questions about cost, access, and health equity.
Full story: https://gethealthbrief.com/story/fda-approves-casgevy-pediatric-sickle-cell-health

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.